A recent report looked at the topic of COVID-19 antiviral prescriptions for older adults. The study focused on people aged 65 and older who were treated as outpatients, not in a hospital, in the United States. The goal was to understand how often these patients received prescriptions for antiviral drugs used to treat COVID-19.
The report did not provide the actual results of the study. It did not share any numbers on how many people got prescriptions, if certain groups were more likely to receive them, or how this might have changed over time. No information was given about the safety of the medications or any side effects in this specific group.
Because the findings are not available, this report cannot tell us anything about current prescription practices or their outcomes. Readers should know that this is simply an announcement that a study was done on this topic. We will need to wait for the full study results to be published to learn what the researchers actually found.